Location History:
- Apex, NC (US) (2015 - 2019)
- Raleigh, NC (US) (2019 - 2021)
Company Filing History:
Years Active: 2015-2025
Title: The Innovative Contributions of Matthew Breen
Introduction
Matthew Breen is a prominent inventor based in Raleigh, NC, known for his significant contributions to veterinary medicine. With a total of 10 patents, he has focused on developing methods and tools that enhance the diagnosis and prognosis of diseases in dogs, particularly in oncology.
Latest Patents
Among his latest patents, Breen has developed a method for chromosomal assessment to diagnose urogenital malignancy in dogs. This invention is directed towards diagnosing bladder cancer in canines, providing a crucial tool for early detection. Additionally, he has created methods for mast cell tumor prognosis, which include techniques for detecting a high-risk phenotype of a mast cell tumor (MCT) in biological samples from mammals, preferably dogs. His work also encompasses the development of kits, PCR probes, and primers designed to detect high-risk MCT.
Career Highlights
Matthew Breen has had a distinguished career, contributing to the field of veterinary oncology through his innovative research and inventions. He has worked at North Carolina State University, where he has been instrumental in advancing the understanding of canine cancers and improving diagnostic methods.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
Matthew Breen's work exemplifies the intersection of innovation and veterinary medicine, making significant strides in the diagnosis and treatment of cancer in dogs. His contributions continue to impact the field positively, enhancing the quality of care for our canine companions.